We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Immuno-Oncology

News List

ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor C firstwordpharma
January 22, 2017
ChemoCentryx, Inc., announced the presentation of results from its immuno-oncology program at the American Society of Clinical Oncology (ASCO) 2017 Gastrointestinal Cancers Symposium being held January 19-21, 2017 in San Francisco, California.
AstraZeneca broadens first-line immuno-oncology NSCLC development programme firstwordpharma
January 18, 2017
AstraZeneca provided an update Tuesday on its late-stage immuno-oncology development programme in first-line non-small-cell lung cancer (NSCLC).
Lilly and Merck expand immuno-oncology collaboration cphi-online
January 13, 2017
Eli Lilly and Merck (MSD) have expanded an existing immuno-oncology collaboration, through a subsidiary, to add a new study of Lilly's Lartruvo (olaratumab) with Keytruda (pembrolizumab) in patients with previously treated advanced or metastatic soft tiss
Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance firstwordpharma
January 06, 2017
Pieris Pharmaceuticals, Inc. announced a broad collaboration in immuno-oncology (IO).

Previous page 1 2 3 4 5 6 7 8 9 10 Next page